Press Archive

  • 2016

    58th Annual General Meeting of the P-D-R 2016

    The Pharma Documentation Ring (P-D-R) held its 58th Annual General Meeting (AGM) in San Francisco, United States of America, from 13th – 16th September 2015. The P-D-R is an association whose member... More

  • Sep 2015

    Press Release: 57th Annual General Meeting of the P-D-R 2015

    The Pharma Documentation Ring (P-D-R) held its 57th Annual General Meeting (AGM) in Zurich, Switzerland, from 23rd – 25th September 2015. The P-D-R is an association whose members represent the info... More

  • 2015

    The P-D-R (Pharma Documentation Ring) hosts a special meeting on “Authentication Technologies – Challenges and Opportunities for the Scientific Corporate Information Centre” 2015

    On June 10th 2015, over 50 delegates representing both P-D-R member companies and industry partners participated in a one day special meeting in Ascot, United Kingdom to discuss authentication technol... More

  • 2014

    56th Annual General Meeting of the P-D-R 2014

    The Pharma Documentation Ring (P-D-R) held its 56th Annual General Meeting (AGM) in Windsor, England, from 23rd - 26th September 2014. The P-D-R is an association whose members represent the scientifi... More

  • 2013

    P-D-R Special Meeting, Brugge, Belgium 28th-29th November 2013

    The Pharma Documentation Ring (P-D-R) held a Special Meeting on Text Mining STM Content on November 28-29, 2013 in Brugge, Belgium. Text mining and related tools have become an integrated part of s... More

  • 2013

    55th Annual General Meeting of the P-D-R 2013

    The Pharma Documentation Ring (P-D-R) held its 55th Annual General Meeting (AGM) in Chicago, USA, from 24th – 27th September 2013. The P-D-R is an association whose members represent the scientific ... More

  • 2012

    54th Annual General Meeting of the P-D-R 2012

    The Pharma Documentation Ring (P-D-R) held its 54th Annual General Meeting (AGM) in Königswinter, Germany, from 18th – 21st September 2012. The P-D-R is an association whose members represent the s... More

  • 2012

    Joint announcement from ALPSP, PDR and STM: Text and data-mining clause agreed by ALPSP, P-D-R and STM

    Pharmaceutical companies will be better able to pursue research using text and data-mining, thanks to an agreement announced today. The Pharma-Documentation-Ring(P-D-R)sample license has been updated to grant text and data-mining rights to use the content to which each of the P-D-R members subscribes. The P-D-R sample license serves as a benchmark used by P-D-R's members to negotiate individual subscription agreements with publishers and other content suppliers. It is regularly updated to enable market demand to meet at the intersection of pharmaceutical research, bio-informatics as well as electronic and scientific publishing.

  • 2011

    53rd Annual General Meeting of the P-D-R 2011

    The Pharma Documentation Ring (P-D-R) held its 53rd Annual General Meeting (AGM) in Heidelberg, Germany, from 26th– 30th September 2011. The P-D-R is an association whose members represent the scien... More

  • 2010

    52nd Annual General Meeting of the P-D-R 2010

    The Pharma Documentation Ring (P-D-R) held its 52nd Annual General Meeting (AGM) in Konstanz, Germany, from 29th September – 1st October 2010. The P-D-R is an association whose members represent th... More

  • 2009

    51st Annual General Meeting of the P-D-R 2009

    The Pharma Documentation Ring (P-D-R) held its 51st Annual General Meeting (AGM) in Leesburg, Virginia, USA from the 22nd – 25th September 2009. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. There was one new corporate member (Takeda) added during the previous 12 months. The 24 member companies continue to account for approximately 60% of the total global turnover of ethical drugs (approximately $500 billion); by far the majority of the top 20 global pharmaceutical companies are P-D-R members. More

  • 2008

    50th Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (P-D-R) held its 50th Annual General Meeting (AGM) in Montreux, Switzerland from the 23rd – 26th September 2008. This year’s meeting celebrated the 50th anniversary of the group’s founding. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. There were two new corporate members (Ferring Pharmaceuticals and UCB) added during the previous 12 months. The 23 member companies continue to account for approximately 60% of the total global turnover of ethical drugs (approximately $500 billion); by far the majority of the top 20 global pharmaceutical companies are P-D-R members.

  • 2007

    49th Annual General Meeting of the P-D-R 2007

    The Pharma Documentation Ring (P-D-R) held its 49th Annual General Meeting (AGM) in Philadelphia, USA from the 25th – 28th September 2007. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. This was the first occasion that the association has held a meeting outside of Europe and is in recognition of an increasing involvement from US headquartered companies and delegates. There was no change to the total number of corporate members during the previous 12 months. The 21 member companies continue to account for approximately 60% of the total global turnover of ethical drugs (approximately $500 billion); by far the majority of the top 20 global pharmaceutical companies are P-D-R members.

  • 2006

    48th Annual General Meeting of the P-D-R 2006

    The Pharma Documentation Ring (P-D-R) held its 48th Annual General Meeting (AGM) in Bracknell, UK from the 26th – 29th September 2006. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. There was no change to the number of corporate members during the previous 12 months. The 21 member companies continue to account for approximately 60% of the total global turnover of ethical drugs (approximately $500 billion); by far the majority of the top 20 global pharmaceutical companies are P-D-R members.

  • 2005

    47th Annual General Meeting of the P-D-R 2005

    The Pharma Documentation Ring (P-D-R) held its 47th Annual General Meeting (AGM) in Bad Nauheim, near Frankfurt, Germany from the 4th – 7th October 2004. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. There was no change to the number of corporate members during the previous 12 months. The 20 member companies continue to account for approximately 60% of the total global turnover of ethical drugs (approximately $500 billion); by far the majority of top 20 global pharmaceutical companies are P-D-R members.

  • 2004

    46th Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (P-D-R) held its 46th Annual General Meeting (AGM) in Bürgenstock, near Lucerne, Switzerland from the 5th – 8th October 2004. The P-D-R is an association which represents the scientific information departments of the leading international R&D-based pharmaceutical corporations. Despite merger and acquisition activity in the pharmaceutical industry, the number of corporate members has remained stable at 22. The latter account for approximately 60% of the total global turnover of ethical drugs (approximately $470 billion in 2004); by far the majority of top 20 global pharmaceutical players are P-D-R members.

  • 2003

    45th Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (P-D-R) held its 45th Annual General Meeting (AGM) in Thame, near Oxford, UK from the 24th – 26th September 2003. The P-D-R is an association whose members represent the scientific information departments of the leading international R&D-based pharmaceutical corporations. The 22 corporate members account for approximately 60% of the total global turnover of ethical drugs (approximately $430 billion); by far the majority of top 20 global pharmaceutical companies are P-D-R members.

  • 2002

    44th Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (P-D-R) held its 44th Annual General Meeting (AGM) in Newmarket, UK from the 8th – 11th October 2002. The P-D-R is an association whose members represent the scientific information departments of the leading R&D-based pharmaceutical corporations. The 23 companies represented account for approximately 60% of the total global turnover of ethical drugs., by far the majority of top 20 global pharmaceutical companies are corporate P-D-R members. Over 45 delegates from 11 different countries in Europe and North America attended this year’s meeting, which was ably hosted by GlaxoSmithKline. An informal reception for delegates prior to the official opening of the meeting was organised by Thompson Derwent.

  • 2002

    Special P-D-R Meeting on Biotechnology Information and Intellectual Property

    April 15 - 16, 2002 - Frankfurt am Main (Germany) – The biotech and genome revolution are already making a massive impact on pharmaceutical drug discovery and development processes, a vast amount of genomic and proteomic data being now available to research and intellectual property functions. This special P-D-R Meeting will be dedicated to these topics, discussing trends and issues with leading experts from both inside and outside the industry. Information/Knowledge Management professionals and bioinformatic specialists from P-D-R member companies will share and discuss best practices of exploiting and manipulating biotechnology information.The Meeting is open solely to P-D-R member companies and special guests.

  • 2001

    43rd Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (P-D-R) held its 43rd Annual General Meeting (AGM) in Kent, UK from the 3rd - 5th October 2001. The P-D-R is an association whose members represent the scientific information departments of the leading R&D-based pharmaceutical corporations. The 24 companies represented account for approximately 60% of the total global turnover of ethical drugs.

  • 2000

    42th Annual General Meeting of the P-D-R

    The Pharma Documentation Ring (PDR) held its 42nd Annual General meeting (AGM) in Cheshire, UK from the 27th September to the 29th September 2000. The PDR is an association whose members represent the scientific information departments of the leading R&D-based pharmaceutical corporations. The 23 companies represented account for more than half of the total global turnover of ethical drugs.

  • 2000

    P-D-R Special Linking Meeting March 2000

    The Pharma Documentation Ring (P-D-R) held a Special Meeting on Linking on the 30-31st March 2000 in Runnymede, UK. Linking is a powerful capability that has emerged from the increased opportunities for R&D scientists to navigate through the scientific and medical literature in the electronic domain as a result of the widespread use of the world wide web, electronic journals, and on-line databases. The P-D-R is an association whose members represent the scientific information departments of the leading R&D-based pharmaceutical corporations. The meeting was attended by a total of 52 delegates, 36 of whom were from 21 different P-D-R member companies, and 16 from invited publishers, on-line information providers and scientific software suppliers.

  • 1999

    41st Annual General Meeting of the P-D-R 1999

    The Pharma Documentation Ring (PDR) held its 41st Annual General meeting in Copenhagen, Denmark from the 29th September to the 1st October 1999. The PDR is an association whose members represent the scientific information departments of the leading R&D-based pharmaceutical corporations. The 28 Companies, who were represented, account for more than half of the total global turnover ($296 billion) of ethical drugs in 1999. This year's successful meeting, excellently organised by Novo Nordisk, was attended by 40 delegates from the member companies, with Lundbeck represented for the first time. The total number of member companies has shown a slight fall over the last 3 years due to continuing consolidation in the Pharmaceutical Industry. The existing PDR Board was re-elected for a further term of 2 years.

  • 1998

    Press Release on the 40th AGM of the PDR

    The Pharma Documentation Ring (PDR) held its 40th Annual General Meeting in Montpellier, France from the 30th September to the 2nd October. The PDR is an association whose members represent the information departments of the leading R&D-based pharmaceutical corporations. The 25 Companies, who were all represented at the meeting, account for more than half of the total global turnover ($xxx billion) of ethical drugs in 1997. This year's successful meeting, excellently organized by Sanofi Recherche, was attended by 42 delegates from the member companies, with Eli Lilly attending for the first time. In addition, 10 former members, including x past presidents attended the 40th anniversary celebrations.

  • 1997

    Press Release for the 39th PDR Annual General Meeting

    The Pharma Documentation Ring (PDR) held its 39th Annual General Meeting in Berlin from 24- 26 September 1997. The PDR is an association whose members consist of representatives from the scientific information departments of, currently 26, R&D-based pharmaceutical corporations, the latter now account for almost half of the total global turnover ($225 billion) of ethical drugs in 1996. This year's successful meeting, excellently organized by Schering AG, was attended by some 40 delegates from all member companies. Merck & Co and Hoffmann La Roche attended for the first time.